[{"address1": "1200 Brickell Avenue", "address2": "Suite 1950 #1183", "city": "Miami", "state": "FL", "zip": "32183", "country": "United States", "phone": "786-432-9792", "website": "https://mirapharmaceuticals.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Itzchak  Angel Ph.D.", "title": "Chief Scientific Advisor", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.47, "open": 1.47, "dayLow": 1.46, "dayHigh": 1.56, "regularMarketPreviousClose": 1.47, "regularMarketOpen": 1.47, "regularMarketDayLow": 1.46, "regularMarketDayHigh": 1.56, "payoutRatio": 0.0, "forwardPE": -3.0612245, "volume": 270875, "regularMarketVolume": 270875, "averageVolume": 1338656, "averageVolume10days": 251060, "averageDailyVolume10Day": 251060, "bid": 1.12, "ask": 1.88, "bidSize": 2, "askSize": 2, "marketCap": 27705600, "fiftyTwoWeekLow": 0.73, "fiftyTwoWeekHigh": 2.7, "fiftyDayAverage": 1.4264, "twoHundredDayAverage": 1.261665, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 25347236, "profitMargins": 0.0, "floatShares": 13372476, "sharesOutstanding": 18470400, "sharesShort": 388885, "sharesShortPriorMonth": 233300, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0211, "heldPercentInsiders": 0.22042, "heldPercentInstitutions": 0.05061, "shortRatio": 0.12, "shortPercentOfFloat": 0.026600001, "impliedSharesOutstanding": 18470400, "bookValue": 0.033, "priceToBook": 45.454544, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -7765054, "trailingEps": -0.47, "forwardEps": -0.49, "52WeekChange": -0.1573034, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 1.5, "targetHighPrice": 17.75, "targetLowPrice": 17.75, "targetMeanPrice": 17.75, "targetMedianPrice": 17.75, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 730475, "totalCashPerShare": 0.042, "totalDebt": 0, "quickRatio": 2.447, "currentRatio": 2.791, "returnOnAssets": -2.53313, "returnOnEquity": -5.5686903, "freeCashflow": -3490330, "operatingCashflow": -6076819, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1691069400000, "postMarketChangePercent": -1.2866656, "shortName": "MIRA Pharmaceuticals, Inc.", "longName": "MIRA Pharmaceuticals, Inc.", "postMarketPrice": 1.4807, "postMarketChange": -0.019299984, "regularMarketChange": 0.03, "regularMarketDayRange": "1.46 - 1.56", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1338656, "fiftyTwoWeekLowChange": 0.77, "fiftyTwoWeekLowChangePercent": 1.0547944, "fiftyTwoWeekRange": "0.73 - 2.7", "fiftyTwoWeekHighChange": -1.2, "fiftyTwoWeekHighChangePercent": -0.44444445, "fiftyTwoWeekChangePercent": -15.730339, "epsTrailingTwelveMonths": -0.47, "epsForward": -0.49, "epsCurrentYear": -0.385, "priceEpsCurrentYear": -3.896104, "fiftyDayAverageChange": 0.073600054, "fiftyDayAverageChangePercent": 0.05159847, "twoHundredDayAverageChange": 0.23833501, "twoHundredDayAverageChangePercent": 0.18890515, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-08-03", "cryptoTradeable": false, "regularMarketChangePercent": 2.04081, "regularMarketPrice": 1.5, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755302341, "regularMarketTime": 1755288001, "exchange": "NCM", "messageBoardId": "finmb_1793899557", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "MIRA Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]